Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.28B
Enterprise Value6.26B
P/E Ratio32.45
PEG Ratio0.12
Price/Sales Ratio5.96
Price/Book Ratio1.68
Enterprise/Revenue5.92
Enterprise/EBITDA26.35

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.18
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue915.12M
Revenue/Share5.83
Gross Profit822.87M
EBITDA233.49M
Net Income165.97M
Diluted EPS1.04

Balance Sheet

Total Cash787.47M
Total Cash/Share5
Total Debt321.63M
Total Debt/Equity0.1
Current Ratio3.05
Book Value Per Share22.29

Price History

52-Week Change-28.78
52-Week High67.98
52-Week Low27.33
Moving Average 50 Days32.8
Moving Average 200 Days40.06

Statistics

Average Volume3.65M
Shares Outstanding159.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.35
Trailing Annual Dividend Yield1.02
Payout Ratio1.16
Last Split FactorN/A
Last Split DateN/A
AD